Market Assessment for an interface between the nervous system and ML-based digital computation to enable nervous system repair and augmentation.

我们已经开发了用于调制和观察的自适应神经植入物Animo。Animo是一个血管，将我们专有的机器学习和神经调节技术植入神经系统，以解释神经活动并使用电神经刺激做出反应。我们的目标是将Animo部署为兽医保健中不受控制的癫痫发作的解决方案。该设备适用于超过250万耐药候选药物，预计手术费用为1万美元，存在数十亿美元的潜在市场。当仅考虑药物难治性癫痫的保险病例(估计约占病例的2.5%)时，潜在的市场规模为7.2亿美元。我们已经与加拿大最先进的兽医医院之一动物健康伙伴公司建立了战略分销合作伙伴关系。我们已经阐明了我们的价值主张，即提供一种设备，为兽医保健领域的失控癫痫提供唯一解决方案。我们已经确定了耐药犬癫痫市场是我们的主要目标。我们请求聘请专业顾问服务的目的是验证和扩展我们的初步市场评估。

We have developed ANIMO, the Adaptive Neural Implant for Modulation and Observation. ANIMO is a vessel to implant our proprietary machine learning and neuromodulation technology within the nervous system to interpret neural activity and to respond using electrical neurostimulation. We aim to deploy ANIMO as the solution for uncontrolled seizures in veterinary healthcare. The device is suitable for over 2.5 million drug-refractory candidates, and with an anticipated procedure cost of $10,000, a multi-billion-dollar potential market exists. When just considering insured cases of drug-refractory epilepsy alone (estimated to be about 2.5% of cases), the potential addressable market size is $720M. We have formed a strategic distribution partnership with one of the most advanced veterinary hospitals in Canada, Animal Health Partners.We have clarified our value proposition as providing a device which offers the only solution for uncontrolled seizures in veterinary healthcare. We have identified the drug-refractory canine epilepsy market segment as our primary target. The purpose of our request for enlist professional consultant services to validate and expand on our preliminary market assessment.